Elizabeth Henry
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Deferasirox, Cholecalciferol, and Azacitidine in the Treatment of Newly Diagnosed AML Patients Over 65 (NCT02341495) | Elizabeth Henry | 2013-02-01 |
Track Elizabeth Henry automatically
Every clearance here is in the API, with alerts when new ones post.